Profile

Russ Geyer, MD

Russ Geyer, MD

Hematology-Oncology

On staff since June 1986

Children's Title: In-patient Clinical Director; Evans Family Endowed Chair in Pediatric Cancer

Academic Title: Professor, Pediatrics

Research Center: Center for Clinical and Translational Research

J. Russell Geyer, MD, is clinical director of the Hematology-Oncology Inpatient Service at Seattle Childrens Hospital and professor of pediatrics and adjunct professor in the Department of Neurological Surgery at the University of Washington School of Medicine. Geyer holds the Evans Family Endowed Chair in Pediatric Cancer at Seattle Children's. Nationally, Geyer is a member of the COG-CNS Brain Tumors Committee and the CNS Steering Committee. Geyer also serves as chairman of the Fred Hutchinson Cancer Research Center Consortium Pediatric Scientific Review Committee. He is chairman of the Pediatric Brain Tumor Consortium (PBTC) Infant Brain Tumor Study.

Recommendations

  • Heather Redmond, WA 07.10.13

    Dr. Geyer was the Oncologist on-call when our daughter was diagnosed with Neuroblastoma at 9 months old. She had lost all neurologic function below the waist, which was an emergent situation. Dr. Geyer moved from MRI, Diagnosis and treatment so rapidly; it was really impressive. Within hours we were checked into a room and my daughter was receiving her first dose of chemo. Nothing ever prepares you to hear that your child has cancer, but Dr. Geyer handled himself with such professionalism, kindness and compassion. He helped answer our immediate questions and let us know how the process would work along with who our doctors and nurses would be. I am so grateful that he reacted so quickly and with such urgency for our daughter.

  • Kendra Ronan, MT 10.08.11

    Dr Geyer and Nurse, Cory, embodied the best of medicine in through my son Hudson's fight with a brain tumor. Their compassionate communication and management of cutting edge treatments empowered us to make the best of a heart breaking situation. I give credit to the staff at Childrens' in Seattle for the cherished extra time we were able to spend with Hudson. The cares we received inspired me to go on to nursing school after our loss. I am now an Obstetrics and Medical/Surgical R.N. in our local facility, caring for laboring moms, thier infants, and a lifespan of surgical patients. The team went over and above the call of duty to be deeply instrumental in our treatment, continued healing as we "pay it forward".

  • Tanya Richland, WA 03.15.11

    Dr. Geyer was our son Aidan's Oncologist during his 2 1/2 year battle with DIPG. His knowledge and care of Aidan went above and beyond what was required of him. He managed to always be truthful and compassionate with the information and decisions that were given to us. We will never be able to thank him and his team enough for the care they gave to Aidan until the end. He will always be one of Aidan's Angels!

  • Jon Ketchikan 01.19.11

    Dr. Geyer is awesome. He is very friendly, and extremely knowledgeable in his field. I am so glad to have had Dr. Geyer in my life. If it weren't for him, who know if I'd be here.

  • Wilbert Bellevue, WA 09.13.12

    Dr. Geyer is awesome. And Cory too. Our son was diagnosed (Glioblastoma Multiforme) when he was 17 months old, and he was lucky that Dr. Geyer took him (well us) under his wing as him primary oncologist. Dr. Geyer always gave us the impression that he would fight for Niels' life, and that we were part of it, always super friendly, super clear, and always taking our floods of questions seriously. Seriously, I don't know what more we could have wished for in his medical team. More than 3 years later, Niels is alive & happy, and the tumor seems to be gone from the MRIs.

Overview

Board Certification(s)

Pediatric Hematology-Oncology
Pediatrics

Medical/Professional School

Wayne State University School of Medicine, Detroit

Residency

Pediatrics, Children's Hospital of Michigan, Detroit
Child Neurology, University of Michigan Hospital, Ann Arbor
Pediatric Hematology-Oncology, University of Washington School of Medicine, Seattle

Research Description

Pediatric Oncology

Research Focus Area

Cancer

Awards and Honors

Award Name Award Description Awarded By Award Date
U.S. News Top Doctor U.S. News and World Report 2012
Seattle Magazine Top Doctor - 2012 Seattle Magazine Top Doctor - 2012 Seattle Magazine 2012
"Guide to America's Top Pediatricians" Consumer's Research Council of America 2009
Department of Pediatrics Faculty Mentor Award University of Washington 2007
Alpha Omega Alpha Society Wayne State University 1976
Sophomore Medical Scholarship Award Wayne State University 1975

Publications

  • Ojemann JG, Partridge SC, Poliakov AV, Niazi TN, Shaw DW, Ishak GE, Lee A, Browd SR, Geyer JR, Ellenbogen RG
    Diffusion tensor imaging of the superior cerebellar peduncle identifies patients with posterior fossa syndrome.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery , 2013 Nov. : 29(11)2071-7
  • Fouladi M, Stewart CF, Blaney SM, Onar-Thomas A, Schaiquevich P, Packer RJ, Goldman S, Geyer JR, Gajjar A, Kun LE, Boyett JM, Gilbertson RJ
    A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
    Journal of neuro-oncology , 2013 Sept. : 114(2)173-9
  • Bona K, Dussel V, Orellana L, Kang T, Geyer R, Feudtner C, Wolfe J
    Economic Impact of Advanced Pediatric Cancer on Families.
    Journal of pain and symptom management , 2013 July 18
  • Yang T, Temkin N, Barber J, Geyer JR, Leary S, Browd S, Ojemann JG, Ellenbogen RG
    Gross total resection correlates with long-term survival in pediatric patients with glioblastoma.
    World neurosurgery , 2013 Mar. : 79(3-4)537-44
  • Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, Rheingold SR, Geyer JR, Alexander SC, Drotar D, Kodish ED
    Communicating and understanding the purpose of pediatric phase I cancer trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2012 Dec. 10 : 30(35)4367-72
  • Ojemann JG, Hersonskey TY, Abeshaus S, Geyer JR, Saneto RP, Novotny EJ, Kollros P, Leary S, Holmes MD
    Epilepsy surgery after treatment of pediatric malignant brain tumors.
    Seizure : the journal of the British Epilepsy Association , 2012 Oct. : 21(8)624-30
  • Blaney SM, Kocak M, Gajjar A, Chintagumpala M, Merchant T, Kieran M, Pollack IF, Gururangan S, Geyer R, Phillips P, McLendon RE, Packer R, Goldman S, Banerjee A, Heideman R, Boyett JM, Kun L
    Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001).
    Journal of neuro-oncology , 2012 Sept. : 109(3)565-71
  • Warren KE, Gururangan S, Geyer JR, McLendon RE, Poussaint TY, Wallace D, Balis FM, Berg SL, Packer RJ, Goldman S, Minturn JE, Pollack IF, Boyett JM, Kun LE
    A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.
    Journal of neuro-oncology , 2012 Feb. : 106(3)643-9
  • Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ
    Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2011 Oct. 20 : 29(30)3999-4006
  • Pollack IF, Stewart CF, Kocak M, Poussaint TY, Broniscer A, Banerjee A, Douglas JG, Kun LE, Boyett JM, Geyer JR
    A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
    Neuro-oncology , 2011 Mar. : 13(3)290-7
  • Haas-Kogan DA, Banerjee A, Poussaint TY, Kocak M, Prados MD, Geyer JR, Fouladi M, Broniscer A, Minturn JE, Pollack IF, Packer RJ, Boyett JM, Kun LE
    Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.
    Neuro-oncology , 2011 Mar. : 13(3)298-306
  • Yang T, Pruthi S, Geyer JR, Ojemann JG
    MRI changes associated with vigabatrin treatment mimicking tumor progression.
    Pediatric blood & cancer , 2010 Dec. 1 : 55(6)1221-3
  • Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM
    A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.
    European journal of cancer (Oxford, England : 1990) , 2010 Dec. : 46(18)3287-93
  • Broniscer A, Baker JN, Baker SJ, Chi SN, Geyer JR, Morris EB, Gajjar A
    Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.
    Cancer , 2010 Oct. 1 : 116(19)4632-7
  • Giussani C, Poliakov A, Ferri RT, Plawner LL, Browd SR, Shaw DW, Filardi TZ, Hoeppner C, Geyer JR, Olson JM, Douglas JG, Villavicencio EH, Ellenbogen RG, Ojemann JG
    DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma.
    NeuroImage , 2010 Aug. 1 : 52(1)217-23
  • Moreno L, Pollack IF, Duffner PK, Geyer JR, Grill J, Massimino M, Finlay JL, Zacharoulis S
    Utility of cerebrospinal fluid cytology in newly diagnosed childhood ependymoma.
    Journal of pediatric hematology/oncology , 2010 Aug. : 32(6)515-8
  • McKibbin T, Zhao W, Tagen M, Daw NC, Furman WL, McGregor LM, Geyer JR, Allen JW, Stewart CF
    Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib.
    European journal of cancer (Oxford, England : 1990) , 2010 July : 46(11)2045-51
  • Kieran MW, Supko JG, Wallace D, Fruscio R, Poussaint TY, Phillips P, Pollack I, Packer R, Boyett JM, Blaney S, Banerjee A, Geyer R, Friedman H, Goldman S, Kun LE, Macdonald T, Pediatric Brain Tumor Consortium
    Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.
    Pediatric blood & cancer , 2009 Feb. : 52(2)169-76
  • Finlay JL, Dhall G, Boyett JM, Dunkel IJ, Gardner SL, Goldman S, Yates AJ, Rosenblum MK, Stanley P, Zimmerman RA, Wallace D, Pollack IF, Packer RJ, Children's Cancer Group
    Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group.
    Pediatric blood & cancer , 2008 Dec. : 51(6)806-11
  • Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE
    Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
    Neuro-oncology , 2008 June : 10(3)341-7
  • Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LE
    Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2007 July 20 : 25(21)3137-43
  • Kletter GB, Sweetser DA, Wallace SF, Sawin RS, Rutledge JC, Geyer JR
    Adrenocorticotropin-secreting pancreatoblastoma.
    Journal of pediatric endocrinology & metabolism : JPEM , 2007 May : 20(5)639-42
  • Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM
    Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
    Neuro-oncology , 2007 Apr, : 9(2)145-60
  • Abel TJ, Chowdhary A, Thapa M, Rutledge JC, Geyer JR, Ojemann J, Avellino AM
    Spinal cord pilocytic astrocytoma with leptomeningeal dissemination to the brain. Case report and review of the literature.
    Journal of neurosurgery , 2006 Dec. : 105(6 Suppl)508-14
  • Freeman BB 3rd, Daw NC, Geyer JR, Furman WL, Stewart CF
    Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients.
    Cancer investigation , 2006 Apr, : 24(3)310-7
  • Douglas JG, Rockhill JK, Olson JM, Ellenbogen RG, Geyer JR
    Cisplatin-based chemotherapy followed by focal, reduced-dose irradiation for pediatric primary central nervous system germinomas.
    Journal of pediatric hematology/oncology , 2006 Jan. : 28(1)36-9
  • Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T, Children's Cancer Group
    Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Oct. 20 : 23(30)7621-31
  • Bobola MS, Finn LS, Ellenbogen RG, Geyer JR, Berger MS, Braga JM, Meade EH, Gross ME, Silber JR
    Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research , 2005 Oct. 15 : 11(20)7405-14
  • Bobola MS, Silber JR, Ellenbogen RG, Geyer JR, Blank A, Goff RD
    O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research , 2005 Apr, 1 : 11(7)2747-55
  • Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR, Packer R, Adamson PC, Jaeckle K, Klenke R, Aikin A, Murphy R, McCully C, Poplack DG
    Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Mar. 1 : 23(7)1555-63
  • Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R
    Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Jan. 20 : 23(3)525-31
  • Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R
    Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2005 Jan. 20 : 23(3)525-31
  • Thomson B, Park JR, Felgenhauer J, Meshinchi S, Holcenberg J, Geyer JR, Avramis V, Douglas JG, Loken MR, Hawkins DS
    Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.
    Pediatric blood & cancer , 2004 Oct. : 43(5)571-9
  • Douglas JG, Barker JL, Ellenbogen RG, Geyer JR
    Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    International journal of radiation oncology, biology, physics , 2004 Mar. 15 : 58(4)1161-4
  • Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP
    A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
    Neuro-oncology , 2003 Jan. : 5(1)8-13
  • Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM
    Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2003 Jan. 1 : 21(1)143-7
  • Packer RJ, Biegel JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LB, Smith M
    Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.
    Journal of pediatric hematology/oncology , 2002 June : 24(5)337-42

Research Funding

Grant Title Grantor Amount Award Date
U10 CA98543 National Childhood Cancer Foundation-NIH/NCI $1,367,150. Jan. 1, 2003 - Feb. 29, 2008
FH #05-103637-03-S0993 FHCRC Damon Runyan $995,000. Jan. 1, 2002 - June 30, 2007